01—Abstract
Summary
Summary of the 8-K filed May 9, 2023. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. held its 2023 Annual Meeting of Shareholders on May 4, 2023, where key governance matters were put to a vote.
The meeting saw strong shareholder support for the re-election of seventeen Equity Directors and the ratification of Ernst & Young LLP as the independent auditor. However, a significant advisory vote against the compensation of named executive officers indicates shareholder concern on this front. Notably, the Company announced that the advisory vote on executive compensation was not approved, with a majority voting against it.
The shareholders did, however, vote for annual advisory votes on executive compensation, a frequency that will be maintained until 2029. In a unique outcome, elections for several Class B Directors did not achieve quorum, leading to these directors continuing as "holdovers" under Delaware law until their successors are elected at the next annual meeting.
02—Key points
Key Highlights
- Shareholder turnout was robust, with 86.27% of Class A and B common stock represented at the Annual Meeting.
- All seventeen proposed Equity Directors were re-elected, demonstrating board continuity and shareholder confidence in the current leadership of these roles.
- Ernst & Young LLP was ratified as the independent public accounting firm for 2023 with strong shareholder approval.
- The advisory vote on the compensation of named executive officers was **not approved**, with a significant majority voting against it.
- Shareholders overwhelmingly approved holding an advisory vote on executive compensation annually, setting this frequency until 2029.
- Elections for Class B Directors in B-1, B-2, and B-3 categories did not achieve quorum, resulting in "holdover" directors who will continue their service until successors are elected.
03—Questions
Frequently Asked Questions
What was the main outcome regarding executive compensation?
The advisory vote on the compensation of CME Group's named executive officers was not approved, indicating shareholder disapproval of the current executive pay structure. Shareholders did, however, vote to continue holding advisory votes on compensation on an annual basis.
What happened with the election of Class B Directors?
For several categories of Class B Directors (B-1, B-2, and B-3), no quorum was achieved during the election process. Consequently, the incumbent directors in these positions will continue to serve as "holdovers" until their successors are duly elected at the 2024 Annual Meeting or their earlier resignation or removal.
What was the shareholder turnout like?
Shareholder participation was strong, with approximately 86.27% of the issued and outstanding Class A and Class B common stock represented at the meeting, either in person or by proxy.
Were there any other significant proposals?
Yes, shareholders re-elected all seventeen proposed Equity Directors and ratified the appointment of Ernst & Young LLP as the company's independent auditor for 2023, both with substantial support.
04—Continue